{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:37:56Z","timestamp":1761561476796},"reference-count":47,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,3,22]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objectives<\/jats:title><jats:p>We aimed to implement a method for glucose measurements that could be used as a comparison method for asessing patients' self-monitoring of blood glucose. Further, we investigated whether pharmacies could achieve an analytical quality comparable to glucose measurements performed in general practice.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Sixteen Norwegian pharmacy employees were trained in glucose measurement, quality control and blood sampling. The comparison method, HemoCue Glucose 201+, was validated in four steps: (1) estimation of the variation between the HemoCue instruments to be used at the 16 pharmacies, (2) comparison between HemoCue results and a laboratory glucose method, (3) monitoring quality by internal quality controls and (4) an external quality-assessment scheme. The pharmacies' results of the external quality assessment were compared to those of 359 general practices.<\/jats:p><\/jats:sec><jats:sec><jats:title>Key findings<\/jats:title><jats:p>The coefficient of variation for HemoCue instruments was 6.1% at the low level and 1.7% at the normal and high levels. Bias was negligible at the normal level. The coefficients of variation for internal quality controls were 4.5, 1.5 and 1.2% for the low, normal and high levels, respectively. All pharmacies achieved good precision and acceptable or good trueness in the external quality assessment. The pharmacies exhibited significantly lower variation between sites (2.2 and 1.2%) than general practices (3.8 and 2.9%) on both external quality-assessment samples.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Given correct training and the establishment of a system of quality assurance, pharmacies are capable of obtaining glucose measurements that can be used as comparison measurements for controlling patients' meters. The pharmacies had external quality-assessment results comparable to general practice.<\/jats:p><\/jats:sec>","DOI":"10.1211\/ijpp.18.01.0004","type":"journal-article","created":{"date-parts":[[2010,10,18]],"date-time":"2010-10-18T16:54:53Z","timestamp":1287420893000},"page":"13-19","source":"Crossref","is-referenced-by-count":4,"title":["Implementation of a method for glucose measurements in community pharmacies"],"prefix":"10.1093","volume":"18","author":[{"given":"Reidun L S","family":"Kjome","sequence":"first","affiliation":[{"name":"Section for General Practice, Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kari","family":"Nerhus","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Quality Improvement of Primary Care Laboratories (NOKLUS), Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sverre","family":"Sandberg","sequence":"additional","affiliation":[{"name":"Norwegian Centre for Quality Improvement of Primary Care Laboratories (NOKLUS), Department of Public Health and Primary Health Care, University of Bergen, Bergen, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2010,3,22]]},"reference":[{"key":"2021030911360240600_b1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1345\/aph.1H638","article-title":"Providing patient care in community pharmacies: practice and research in Finland","volume":"41","author":"Bell","year":"2007","journal-title":"Ann Pharmacother"},{"key":"2021030911360240600_b2","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1001\/archinte.168.21.2355","article-title":"A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN)","volume":"168","author":"McLean","year":"2008","journal-title":"Arch Intern Med"},{"key":"2021030911360240600_b3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1464-5491.2007.02143.x","article-title":"The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia","volume":"24","author":"Krass","year":"2007","journal-title":"Diabet Med"},{"key":"2021030911360240600_b4","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1331\/JAPhA.2007.06104","article-title":"Impact of pharmacy care services on patients' perceptions of health care quality for diabetes","volume":"47","author":"Nau","year":"2007","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"2021030911360240600_b5","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11096-006-9003-0","article-title":"A pharmacotherapy follow-up program in patients with type-2 diabetes in community pharmacies in Spain","volume":"28","author":"Fornos","year":"2006","journal-title":"Pharm World Sci"},{"key":"2021030911360240600_b6","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1023\/B:PHAR.0000013465.24857.a8","article-title":"Pharmaceutical care model for patients with type 2 diabetes: integration of the community pharmacist into the diabetes team\u2013a pilot study","volume":"26","author":"Wermeille","year":"2004","journal-title":"Pharm World Sci"},{"key":"2021030911360240600_b7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1331\/108658003321480713","article-title":"The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program","volume":"43","author":"Cranor","year":"2003","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"2021030911360240600_b8","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1086-5802(16)31059-2","article-title":"Pharmaceutical care services and results in project ImPACT: hyperlipidemia","volume":"40","author":"Bluml","year":"2000","journal-title":"J Am Pharm Assoc (Wash)"},{"key":"2021030911360240600_b9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.diabres.2006.06.022","article-title":"Pharmacy diabetes care program: analysis of two screening methods for undiagnosed type 2 diabetes in Australian community pharmacy","volume":"75","author":"Krass","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"2021030911360240600_b10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1331\/154434506777069598","article-title":"Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals","volume":"46","author":"Snella","year":"2006","journal-title":"J Am Pharm Assoc"},{"key":"2021030911360240600_b11","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1331\/154434504773062609","article-title":"Regional osteoporosis screening, referral, and monitoring program in community pharmacies: findings from Project ImPACT: osteoporosis","volume":"44","author":"Goode","year":"2004","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2021030911360240600_b12","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1136\/qshc.2006.020883","article-title":"Chlamydia testing in community pharmacies: evaluation of a feasibility pilot in south east London","volume":"16","author":"Baraitser","year":"2007","journal-title":"Qual Saf Health Care"},{"key":"2021030911360240600_b13","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11096-006-9034-6","article-title":"Sequential screening for diabetes\u2013evaluation of a campaign in Swiss community pharmacies","volume":"28","author":"Hersberger","year":"2006","journal-title":"Pharm World Sci"},{"key":"2021030911360240600_b14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1331\/1544345052843093","article-title":"Impact on medication use and adherence of Australian pharmacists' diabetes care services","volume":"45","author":"Krass","year":"2005","journal-title":"J Am Pharm Assoc (Wash)"},{"issue":"4","key":"2021030911360240600_b15","first-page":"S134","article-title":"Effect of diabetes drug counseling by pharmacist, diabetic disease booklet and special medication containers on glycemic control of type 2 diabetes mellitus: a randomized controlled trial","volume":"88","author":"Suppapitiporn","year":"2005","journal-title":"J Med Assoc Thai"},{"key":"2021030911360240600_b16","first-page":"353","article-title":"Drug related problems identified by European community pharmacists in patients discharged from hospital","volume":"26","author":"Paulino","year":"2004","journal-title":"Pharm World Sci"},{"key":"2021030911360240600_b17","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1592\/phco.27.7.1040","article-title":"Tobacco interventions delivered by pharmacists: a summary and systematic review","volume":"27","author":"Dent","year":"2007","journal-title":"Pharmacotherapy"},{"key":"2021030911360240600_b18","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1345\/aph.1K151","article-title":"Sensitivity of patient outcomes to pharmacist interventions. Part I: systematic review and meta-analysis in diabetes management","volume":"41","author":"Machado","year":"2007","journal-title":"Ann Pharmacother"},{"key":"2021030911360240600_b19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1211\/ijpp.13.4.0001","article-title":"Effectiveness and acceptability of community pharmacy-based interventions in type 2 diabetes: a critical review of intervention design, pharmacist and patient perspectives","volume":"13","author":"Blenkinsopp","year":"2005","journal-title":"Int J Pharm Pract"},{"key":"2021030911360240600_b20","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1211\/0022357055551","article-title":"Pharmaceutical care services: a systematic review of published studies, 1990 to 2003, examining effectiveness in improving patient outcomes","volume":"13","author":"Roughead","year":"2005","journal-title":"Int J Pharm Pract"},{"key":"2021030911360240600_b21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s11096-007-9164-5","article-title":"Diabetes care in Norwegian pharmacies: a descriptive study","volume":"30","author":"Kjome","year":"2008","journal-title":"Pharm World Sci"},{"key":"2021030911360240600_b22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1211\/ijpp.15.1.0008","article-title":"Pharmaceutical care of the patient with diabetes mellitus: pharmacists' priorities for services and educational needs in Scotland","volume":"15","author":"Douglas","year":"2007","journal-title":"Int J Pharm Pract"},{"issue":"9A","key":"2021030911360240600_b23","doi-asserted-by":"crossref","first-page":"1S","DOI":"10.1016\/j.amjmed.2005.07.055","article-title":"The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference","volume":"118","author":"Bergenstal","year":"2005","journal-title":"Am J Med"},{"key":"2021030911360240600_b24","first-page":"835","article-title":"Self-monitoring of blood glucose: benefits and utilization","volume":"32","author":"Austin","year":"2006","journal-title":"Diabetes Educ"},{"issue":"1","key":"2021030911360240600_b25","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.2337\/dc08-S012","article-title":"Standards of medical care in diabetes\u20132008","volume":"31","author":"American Diabetes Association","year":"2008","journal-title":"Diabetes Care"},{"key":"2021030911360240600_b26","first-page":"F352","volume-title":"Clinical Diagnostics Growth Partnership Service: Strategic Analysis Service. Global In Vitro Diagnostics Market Outlook 2005","author":"Sullivan","year":"2005"},{"key":"2021030911360240600_b27","volume-title":"Bransjestatistikk [Trade statistics]","author":"Norges apotekerforening [homepage on the internet]"},{"issue":"240","key":"2021030911360240600_b28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1080\/00365510500235996","article-title":"Quality control of SMBG in clinical practice","volume":"65","author":"Solnica","year":"2005","journal-title":"Scand J Clin Lab Invest"},{"key":"2021030911360240600_b29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/014572179902500107","article-title":"A computerized model for home glucose monitoring proficiency testing: efficacy of an innovative testing program","volume":"25","author":"Schrot","year":"1999","journal-title":"Diabetes Educ"},{"key":"2021030911360240600_b30","first-page":"1","article-title":"Assuring the accuracy of home glucose monitoring","volume":"15","author":"Alto","year":"2002","journal-title":"J Am Board Fam Pract"},{"key":"2021030911360240600_b31","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/014572170002600610","article-title":"Identifying variables associated with inaccurate self-monitoring of blood glucose: proposed guidelines to improve accuracy","volume":"26","author":"Bergenstal","year":"2000","journal-title":"Diabetes Educ"},{"key":"2021030911360240600_b32","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/bmj.318.7181.460","article-title":"Meta-analysis of diabetes care in general practice. All glucose meters must be subject to formal quality control measures. Letter to the Editor","volume":"318","author":"Barlow","year":"1999","journal-title":"BMJ"},{"key":"2021030911360240600_b33","volume-title":"NSAMs handlingsprogram for diabetes [NSAM diabetes plan of action]","author":"Claudi","year":"2000"},{"issue":"1","key":"2021030911360240600_b34","first-page":"S62","article-title":"Self-monitoring of blood glucose","volume":"19","author":"American Diabetes Association","year":"1996","journal-title":"Diabetes Care"},{"key":"2021030911360240600_b35","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1373\/clinchem.2006.068114","article-title":"Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose","volume":"52","author":"Kristensen","year":"2006","journal-title":"Clin Chem"},{"key":"2021030911360240600_b36","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bmj.322.7297.1285","article-title":"Point of care testing","volume":"322","author":"Price","year":"2001","journal-title":"BMJ"},{"key":"2021030911360240600_b37","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1373\/clinchem.2008.107052","article-title":"Traceability in laboratory medicine","volume":"55","author":"Vesper","year":"2009","journal-title":"Clin Chem"},{"key":"2021030911360240600_b38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/01.poc.0000232576.13891.9a","article-title":"Quality assurance of self-monitoring of blood glucose at the general practitioner's office","volume":"5","author":"Kristensen","year":"2006","journal-title":"Point Care"},{"key":"2021030911360240600_b39","volume-title":"The Reference System for the Clinical Laboratory: Criteria for Development and Credentialing of Methods and Materials for Harmonization of Results; Approved Guideline. NCCLS publication NRSCL13-A","author":"Clinical and Laboratory Standards Institute","year":"2008"},{"key":"2021030911360240600_b40","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/clinchem\/40.12.2223","article-title":"External quality assessment in primary health care by using fresh whole blood","volume":"40","author":"Raabo","year":"1994","journal-title":"Clin Chem"},{"key":"2021030911360240600_b41","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1080\/00031305.1996.10473537","article-title":"Confidence intervals for a normal coefficient of variation","volume":"50","author":"Vangel","year":"1996","journal-title":"Am Statistician"},{"key":"2021030911360240600_b42","volume-title":"Utpr\u00f8ving av HemoCue Glucose 201 [Evaluation of HemoCue Glucose 201]","author":"Skandinavian Evaluation of Laboratory Equipment for Primary Health Care (SKUP)"},{"key":"2021030911360240600_b43","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/00365519950185229","article-title":"Current databases on biological variation: pros, cons and progress","volume":"59","author":"Ricos","year":"1999","journal-title":"Scand J Clin Lab Invest"},{"key":"2021030911360240600_b44","doi-asserted-by":"crossref","first-page":"834","DOI":"10.2337\/diacare.27.3.834","article-title":"The need for separate performance goals for glucose sensors in the hypoglycemic, normoglycemic, and hyperglycemic ranges","volume":"27","author":"Klonoff","year":"2004","journal-title":"Diabetes Care"},{"key":"2021030911360240600_b45","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/152091503322526969","article-title":"Performance evaluation of blood glucose monitoring devices","volume":"5","author":"Chen","year":"2003","journal-title":"Diabetes Technol Ther"},{"key":"2021030911360240600_b46","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1331\/1544-3191.46.5.594.Rodis","article-title":"Stepwise approach to developing point-of-care testing services in the community\/ambulatory pharmacy setting","volume":"46","author":"Rodis","year":"2006","journal-title":"J Am Pharm Assoc (2003)"},{"key":"2021030911360240600_b47","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1345\/aph.1D212","article-title":"Point-of-care testing: an introduction","volume":"38","author":"Gutierres","year":"2004","journal-title":"Ann Pharmacother"}],"container-title":["International Journal of Pharmacy Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fijpp.18.01.0004","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/18\/1\/13\/36457891\/ijpp.18.01.0004.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/ijpp\/article-pdf\/18\/1\/13\/36457891\/ijpp.18.01.0004.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T13:32:26Z","timestamp":1711891946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ijpp\/article\/18\/1\/13\/6130394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,3,22]]},"published-print":{"date-parts":[[2010,3,22]]}},"URL":"https:\/\/doi.org\/10.1211\/ijpp.18.01.0004","relation":{},"ISSN":["0961-7671","2042-7174"],"issn-type":[{"value":"0961-7671","type":"print"},{"value":"2042-7174","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2010,2]]},"published":{"date-parts":[[2010,2]]}}}